Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (3): 273-275.DOI: 10.3969/j.issn.1673-8640.2018.03.020
• Orginal Article • Previous Articles
Received:2016-12-23
Online:2018-03-20
Published:2018-04-19
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.03.020
| 血常规 | WBC计数（×109/L） | RBC计数（×1012/L） | 血红蛋白（g/L） | 血小板（×109/L） | WBC分类方式 |
|---|---|---|---|---|---|
| 第1次 | 5.40 | 2.41↓ | 69.00 ↓ | 92.00 | 手工分类 |
| 第2次 | 6.34 | 2.01↓ | 59.00 ↓ | 94.00 | 仪器分类 |
| 血常规 | WBC计数（×109/L） | RBC计数（×1012/L） | 血红蛋白（g/L） | 血小板（×109/L） | WBC分类方式 |
|---|---|---|---|---|---|
| 第1次 | 5.40 | 2.41↓ | 69.00 ↓ | 92.00 | 手工分类 |
| 第2次 | 6.34 | 2.01↓ | 59.00 ↓ | 94.00 | 仪器分类 |
| 1 | 孙雪梅. 血常规检出血液病123例分析[J]. 世界最新医学信息文摘(连续型电子期刊),2015,15(1):129. |
| 2 | 辛小明. 血涂片镜检在血常规检查中的意义[J]. 医技与临床,2012,16(25):3343-3344. |
| 3 | 高华强, 王志清, 朱文艳, 等. 伊马替尼治疗慢性粒细胞性白血病致急性肾功能损害一例[J].中华临床医师杂志(电子版),2013,7(15):7320-7321. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
